Unsatisfactory efficacy in randomized study of reduced-dose CPX-351 for medically less fit adults with newly diagnosed acute myeloid leukemia or other high-grade myeloid neoplasm
Roland B. Walter,
Megan Othus,
Kaysey F. Orlowski,
Emily N. McDaniel,
Bart L. Scott,
Pamela S. Becker,
Mary-Elizabeth M. Percival,
Paul C. Hendrie,
Bruno C. Medeiros,
Michael T. Chiarella,
Arthur C. Louie,
Elihu H. Estey
Affiliations
Roland B. Walter
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA;Department of Epidemiology, University of Washington, Seattle, WA, USA
Megan Othus
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Kaysey F. Orlowski
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Emily N. McDaniel
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Bart L. Scott
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA, USA
Pamela S. Becker
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA
Mary-Elizabeth M. Percival
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA
Paul C. Hendrie
Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA
Bruno C. Medeiros
Stanford University, CA, USA
Michael T. Chiarella
Jazz Pharmaceuticals, Ewing, NJ, USA
Arthur C. Louie
Jazz Pharmaceuticals, Ewing, NJ, USA
Elihu H. Estey
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA
